These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6804222)

  • 1. Increased dipropylacetic acid bioavailability from dipropylacetamide by food.
    Pisani F; D'Agostino AA; Fazio A; Oteri G; Primerano G; Di Perri R
    Epilepsia; 1982 Apr; 23(2):115-21. PubMed ID: 6804222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide.
    Pisani F; Fazio A; Oteri G; Di Perri R
    Ther Drug Monit; 1981; 3(3):297-301. PubMed ID: 6798719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma level of dipropylacetamide and dipropylacetic acid and effect of these drugs on 5-hydroxytryptamine metabolism in mouse brain.
    Whitton PS; Oresković D; Jernej B; Radacić M; Plavsić F; Bulat M
    Biomed Pharmacother; 1986; 40(5):191-3. PubMed ID: 2431727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG and anticonvulsant effects of dipropylacetic acid and dipropylacetamide in the baboon Papio papio.
    Ehlers CL; Mulbry LW; Killam EK
    Electroencephalogr Clin Neurophysiol; 1980 Aug; 49(3-4):391-400. PubMed ID: 6158417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patients.
    Pisani F; Spina E; Trunfio C; Fazio A; Oteri G; Di Perri R
    Ital J Neurol Sci; 1983 Jun; 4(2):173-7. PubMed ID: 6413455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary data on dipropylacetamide absorption in rats.
    Pisani F; De Sarro A; Fazio A; Oteri G
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1541-5. PubMed ID: 6779834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of valproic acid under fasting/nonfasting regimens.
    Chun AH; Hoffman DJ; Friedmann N; Carrigan PJ
    J Clin Pharmacol; 1980 Jan; 20(1):30-6. PubMed ID: 6766956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meal-dependent absorption of enteric-coated sodium valproate.
    Levy RH; Cenraud B; Loiseau P; Akbaraly R; Brachet-Liermain A; Guyot M; Gomeni R; Morselli PL
    Epilepsia; 1980 Jun; 21(3):273-80. PubMed ID: 6769666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats.
    Pisani F; Fazio A; Oteri G; Di Perri R
    J Pharm Pharmacol; 1982 Jan; 34(1):45-6. PubMed ID: 6121031
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the enteral absorption of valproic acid (author's transl)].
    Oelkers W; Stoffels G; Schäfer H; Reith H
    Arzneimittelforschung; 1977; 27(5):1088-90. PubMed ID: 328020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some clinical pharmacological aspects of n-dipropylacetamide.
    Pisani F; Di Perri R
    Ital J Neurol Sci; 1980 Oct; 1(4):245-9. PubMed ID: 6802780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of food on valproic acid absorption.
    Hamilton RA; Garnett WR; Kline BJ; Pellock JM
    Am J Hosp Pharm; 1981 Oct; 38(10):1490-3. PubMed ID: 6794365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of enteric-coated valproic acid.
    Albright PS; Bruni J; Suria D
    Ther Drug Monit; 1984; 6(1):21-3. PubMed ID: 6424275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in absorption lag time of pyridoxal phosphate under fasting and pre- and post-meal conditions.
    Takahashi H; Ogata H; Nagai N; Sugito K; Shimamura H
    Biopharm Drug Dispos; 1994 Aug; 15(6):505-17. PubMed ID: 7993988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects.
    Zimmermann T; Yeates RA; Albrecht M; Laufen H; Wildfeuer A
    Int J Clin Pharmacol Res; 1994; 14(3):87-93. PubMed ID: 7883389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, food.
    Young MA; Lettis S; Eastmond R
    Br J Clin Pharmacol; 1998 Jan; 45(1):31-5. PubMed ID: 9489591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of food on absorption of mefenamic acid from two commercial capsules differing in bioavailability under the fasting state.
    Hamaguchi T; Shinkuma D; Yamanaka Y; Mizuno N
    J Pharmacobiodyn; 1987 Jan; 10(1):21-5. PubMed ID: 3585692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of food on the absorption of oral ziprasidone.
    Miceli JJ; Glue P; Alderman J; Wilner K
    Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.